Table 3.

The average effect of multiple comorbidities* on fibromyalgia (FM) and FM-related variables in 12,215 patients.

No. ComorbiditiesComorbidity Prevalence (%)PSD Average Comorbidity EffectWPI Average Comorbidity EffectSSS Average Comorbidity EffectFM Average Comorbidity EffectFM %, Comorbidity (+) vs Comorbidity (–)WSP, Average Comorbidity Effect vsWSP %, Comorbidity (+) Comorbidity (–)
051.7
≥ 148.33.0 (2.7–3.3)1.8 (1.6–2.0)1.2 (1.1–1.3)12.2 (10.6–13.8)32.6 vs 20.413.4 (11.5–15.2)59.2 vs 45.6
128.92.0 (1.7–2.3)1.2 (1.0–1.5)0.8 (0.7–0.9)7.5 (5.7–9.3)27.9 vs 20.410.5 (8.5–12.6)56.1 vs 45.6
212.54.0 (3.6–4.4)2.4 (2.1–2.7)1.6 (1.4–1.7)16.7 (14.0–19.4)37.1 vs 20.416.3 (13.5–19.2)61.9 vs 45.6
34.55.8 (5.1–6.5)3.6 (3.0–4.2)2.2 (2.0–2.5)26.4 (21.7–31.2)46.0 vs 20.425.7 (21.0–30.4)71.3 vs 45.6
4+2.57.8 (6.5–9.0)4.7 (3.7–5.7)3.1 (2.7–3.5)34.9 (27.2–42.6)55.2 vs 20.426.8 (19.7–34.0)72.4 vs 45.6
  • * Does not include psychological comorbidity. Data are % (95% CI) unless otherwise indicated. Comorbidities range from 0 to 11. PSD: polysymptomatic distress scale; WPI: widespread pain index; SSS: symptom severity score; WSP: widespread pain.